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ABSTRACT 
Wilson's disease is a rare metabolic disorder involving copper metabolism may 
present with hepatic, neurological and psychiatric manifestations. We present a case 
of Wilson's disease with behavioral symptoms, which responded to risperidone. 
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INTRODUCTION 
Wilson disease is a rare but major 
metabolic disorder involving copper me-
tabolism and is associated with abnormal 
liver functions. Hepato-lenticular degenera-
tion (Wilson disease) occurs more fre-
quendy in male, is usually detected during 
adolescence, half of the patients have onset 
before 16 years of age. Forty percept 
patients first show hepatic dysfunction , 40 
% neurological symptoms and 20% with 
psychiatric disorder or behavioral disorder. 
It mostly presents with sudden and change-
able mood swings; anger explosiveness which 
leads to impaired performance by eventual 
brain damage with memory loss if un-
treated. It may be confused with adolescent 
crisis or schizophrenia. (Lipkins, 1999) 
We present a case report of a patient 
who initially presented with emotional dis-
turbances with psychotic features, later di-
agnosed as Wilson disease, in whom 
behavioral symptoms responded to 
Risperidone.. 
CASE REPORT 
Mr. A, 11 years old male child from non-
consanguinous marriage coming from middle 
class, based at air force was referred from 
pediatric OPD. He denied any complaints 
except that he was teased by classmates as 
"mad". According to parents, the child cried 
easily, was restless and talked irrelevandy. 
Symptoms started after history of mild 
fever during school hours and had been 
given antipyretic drug. 
Parents had noticed changes in his be-
haviour when he came from school one day 
prior to psychiatric consultation. He was 
crying and complaining about the teasing by 
peers as "mad" and wanted reassurance and 
asked the mother if he is mad. He talked 
irrelevantly that father is dead and so 
momer should not put bindi on her forehead 
(a sign of being married and husband being 
alive). He was tense, anxious and was not 
able to study. Though sleep was normal he 
did not take food well. Parents initially 
thought there was teasing to harass him as 
he was clever and topper in the class, and 
so he is disturbed and he will be soon all 
right 
Child was well oriented to time, place 
and person, had delusion of reference but 
no high mood or grandiosiry at the time 
of the first consultation. 
The child had similar behavioral symp-
toms without any reason when he had fever 
6 years back and was treated with 
paracetamol. He improved within a day 
without any psychiatric intervention. 
He is living in a nuclear family with 
parents and younger sister. There was no 
family history of any psychiatric illness. No 
prenatal, perinatal, or postnatal complica-
tions. Developmental milestones were nor-
mal. Child began attending school at 6 years 
of age. Currently studying in 6th standard, 
he was very good in studies. 
On examination he was consisous, co-
operative oriented to time, place and person. 
Psychomotor agitation was present, child 
was not able to sit on chair for long time 
and looked anxious and asked the clinician 
and wanted confirmation that he is not 
mad. He reported his mood as euthymic but 
affect was restricted. There were no 
hallucinations. 
Provisional Diagnosis was made 
1. Anxiety disorder 
2. Brief psychotic disorder possibly due 
to general medical condition or drug 
induced. 
He was given alprazolam 0.25 mg three 
times a day and was asked to come for 
follow-up. After 3 days when he came for 
second visit, he improved in terms of crying 
spells but still other features were present. 
Alprazolam was stopped and Risperidone 1 
mg /day with Trihexiphenidyl 2 mg /day 
were prescribed. On second follow-up after 
7 days, he was not crying, did not complain 
of teasing, was talking relevandy, but was 
not taking interest in surroundings. On that 
day he complained of abdominal pain for 
which pediatric reference was made with 
reduction of dose of Risperidone to 0.5 mg 
per day. 
After reducing the dose there was wors-
ening, of symptoms, the child started 
muttering and the dose was raised to 3 mg 
per day he improved within a week, the 
dose was reduced. 
When he came within a few days for 
follow-up, there was worsening, mood symp-
toms like unusual cheerfulness and sleep 
disturbances were present. Mood stabilizer 
sodium valproate 400mg per day was added. 
After a week, he was hospitalized as he 
was not improving and was investigated 
fully with routine blood counts, fundus 
examinanon, Ultrasonography (USG) abdo-
men as had complained of abdominal pain. 
During indoor treatment, he improved 
almost fully within two days after increasing 
doses of risperidone to 3 mg per day The 
fundus examination was normal and USG 
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showed mild heparomegaly. Child was trans-
ferred to pediatric indoor. Pediatrician ad-
vised examination of Kayser-Fleiseher ring 
(KF ring) to evaluate for Wilson disease. 
Slit-lamp examination showed KF ring, hence 
Serum Caeruloplasmin level was advised. 
Serum caeruloplasmin was 6.2 ug/dl (normal 
- 25-63ug/di) level and mereafter copper 
level and total urine copper level were 
advised. 
Child was given D Penicillamine 250 mg 
once a day with zinc sulphate monosulphate 
137.5 mg (equivalent to 50 mg of essential 
zinc) and pyridoxine 10 mg per day for 15 
days. 
As child improve behaviourally, valporate 
was tapered off widiin 3 days and risperidone 
3 mg per day was continued with 
trihexyphenidyl 2 mg per day and asked for 
follow up after 15 days. 
When he came back, 24 hours urine 
copper level was 6 (average 53.9 for people 
age more than 10 years) and s. copper level 
was 203 (normal 75-150 |Xg%). Pediatrician 
increased the doeses of D. Penicillamine to 
250 mg ti.d and Pyridoxide 40 mg / day 
with zinc 137.5 mg/day. 
Child is maintaining behavioral 
improvement on 3 mg per day resperidone 
and 2 mg trihexyphenidyl HCI per day. 
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